Author

Amy Rogers

Clinical Research Fellow, University of Dundee - Cited by 737 - Clinical Trials - Comparative Effectiveness - Drug safety - Primary Care - Learning Healthcare Systems

Biography

Dr. Amy Rogers is currently working as senior researcher . He/Sheowns number of International publications . She is not only a reviewer board member in  international ,( peer reviewed , ESCI & Pubmed indexed )journals but also Editorial / Advisory Board Member in  International Journals . 
Title
Cited by
Year
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
IS Mackenzie, I Ford, G Nuki, J Hallas, CJ Hawkey, J Webster, SH Ralston, ...The Lancet 396 (10264), 1745-1757, 2020202
200
2020
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...The Lancet Oncology 22 (11), 1507-1517, 2021202
149
2021
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label …
IS Mackenzie, A Rogers, NR Poulter, B Williams, MJ Brown, DJ Webb, ...The Lancet 400 (10361), 1417-1425, 2022202
65
2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
IS Mackenzie, CJ Hawkey, I Ford, N Greenlaw, F Pigazzani, A Rogers, ...The Lancet 400 (10359), 1195-1205, 2022202
43
2022
Sex, gender, and medical data
S Bewley, M McCartney, C Meads, A Rogersbmj 372, 2021202
22
2021
Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
J Coyle, A Rogers, R Copland, G De Paoli, TM MacDonald, IS Mackenzie, ...British Journal of Clinical Pharmacology 88 (3), 1031-1042, 222
20
2022
A systematic review of methods used to conduct decentralised clinical trials
A Rogers, G De Paoli, S Subbarayan, R Copland, K Harwood, J Coyle, ...British Journal of Clinical Pharmacology 88 (6), 2843-2862, 2022202
13
2022
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
A Rogers, E Rooke, S Morant, G Guthrie, A Doney, A Duncan, ...BMJ open 12 (6), e060583, 2022202
7
2022
Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study
T Anbarasan, A Rogers, DA Rorie, JW Kerr Grieve, TM MacDonald, ...Journal of human hypertension 36 (1), 32-39, 2022202
7
2022
Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported …
A Rogers, I Morrison, DA Rorie, IS Mackenzie, TM MacDonaldBMJ open 8 (6), e021890, 2018201
5
2018
Factors influencing home blood pressure monitor ownership in a large clinical trial
T Anbarasan, A Rogers, DA Rorie, JWK Grieve, RWV Flynn, ...Journal of human hypertension 36 (3), 325-332, 2022202
4
2022
D1. 1 First set of recommendations for RDCTs (to be implemented in the pan-EU pilot DCT)
A Rogers, I Mackenzie, H KimberleyTrials@ Home, 2020202
4
2020
Does the provision of a DVD-based audio-visual presentation improve recruitment in a clinical trial? A randomised trial of DVD trial invitations
A Rogers, RWV Flynn, IS Mackenzie, TM MacDonaldBMC Medical Research Methodology 19 (1), 1-6, 2019201
3
2019
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension-2021 NHLBI Workshop Report
ML Gumz, D Shimbo, M Abdalla, RC Balijepalli, C Benedict, Y Chen, ...Hypertension 80 (), 50-522, 20220
3
2023
Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide …
A Rogers, A Flynn, IS Mackenzie, L McConnachie, R Barr, RWV Flynn, ...Trials , 1-9, 010
2
2021
Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: The treatment in morning versus evening (TIME …
K Vickneson, A Rogers, T Anbarasan, DA Rorie, TM MacDonald, ...Journal of Human Hypertension 36 (1), 1099-1105, 0
2
2022
Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic
C Gao, M Peters, P Kurver, T Anbarasan, K Jayaraajan, T Manning, ...BJU international 130 (6), 83-831, 0
2
2022
When innovation outpaces regulations: The legal challenges for direct‐to‐patient supply of investigational medicinal products
M Malone, P Ferguson, A Rogers, IS Mackenzie, DA Rorie, ...British Journal of Clinical Pharmacology 88 (3), 5-42, 2022202
1
2022
Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method
A Rogers, G Craig, A Flynn, I Mackenzie, T MacDonald, A DoneyTrials 2 (), -5, 2020202
1
2020
A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs)
J Coyle, A Rogers, R Copland, G De Paoli, TM MacDonald, IS MackenzieTrials 23 (), -, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=GUWo8tQAAAAJ

Cited by
Citations 737
h-index 11
i10-index 11
Recommended Journals
Open Access Journals